11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148505/0/en/Amneal-Receives-U-S-FDA-Approval-of-Sodium-Oxybate-Oral-Solution.html
10 Sep 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203631
05 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/05/3145233/0/en/Avadel-Pharmaceuticals-to-Present-New-Data-on-LUMRYZ-sodium-oxybate-for-Extended-Release-Oral-Suspension-at-World-Sleep-2025.html
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107346/0/en/Avadel-Pharmaceuticals-Announces-Unanimous-Appeals-Court-Decision-Upholding-FDA-Approval-of-LUMRYZ-in-Narcolepsy-in-Administrative-Procedure-Act-Litigation.html
28 Jun 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/policy/ema-starts-review-of-sodium-oxybate-in-alcohol-dependence-17323
05 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/05/3094267/0/en/Avadel-Pharmaceuticals-Receives-Orphan-Drug-Designation-from-FDA-for-LUMRYZ-sodium-oxybate-for-Extended-Release-Oral-Suspension-for-the-Treatment-of-Idiopathic-Hypersomnia.html